Journal article

Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia

Zanfina Ademi, Kumar Pasupathi, Danny Liew

European Journal of Preventive Cardiology | SAGE PUBLICATIONS LTD | Published : 2015

DOI: 10.1177/2047487313514019

Grants

Funding Acknowledgements

Kumar Pasupathi has received research grants from pfizer Australia. Danny Liew has received honoraria and research grants from pfizer Australia.

Citation metrics

7Web of Science
8Scopus

Keywords

Cost Savings
Rivaroxaban
Science & Technology
Computer Simulation
Oral Anticoagulant Drugs
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cost-Benefit Analysis
Hemorrhage
Treatment Outcome
Metaanalysis
Predictors
Pyridones
Risk Factors
Cost-Effectiveness
Cardiovascular System & Cardiology
Prevalence
Antithrombotic Therapy
Models, Economic
Quality-Adjusted Life Years
Stroke
Medication Compliance
Risk Assessment
Time Factors
Stroke Prevention
Drug Costs
Pyrazoles
Warfarin
Randomized Controlled Trials As Topic
Markov Chains
Atrial Fibrillation
Humans
Decision Support Techniques
Population
Australia
Dabigatran